Unknown

Dataset Information

0

The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.


ABSTRACT:

Background and purpose

Our previous study showed that SM905, a novel artemisinin derivative, exhibited potent immunosuppressive activity. In this study, we evaluate preventive and therapeutic effect of SM905 on collagen-induced arthritis (CIA) in DBA/1 mice, and investigate its mechanisms both in inflammatory and autoimmune aspects of the disease.

Experimental approach

CIA was induced by type II bovine collagen (CII) in DBA/1 mice. SM905 was given orally either before (continuously 1 day before booster immunization) or after disease onset (continuously 14 days after booster immunization). Disease incidence and severity were monitored, mRNA expression of proinflammatory mediators was determined by real-time PCR, purified T cell proliferation was assessed using [(3)H]-thymidine incorporated assay, and T helper (Th) 17/Th1/Th2 type cytokine production was examined by ELISA.

Key results

Oral treatment with SM905 delayed disease onset, reduced arthritis incidence and severity, and suppressed the enhanced expression of pro-inflammatory cytokines, chemokines and chemokine receptors in draining lymph nodes. The CII-induced T cell proliferation and production of interleukin (IL)-17A by T cells were strikingly inhibited. Correspondingly, the mRNA expression of IL-17A and RORgamma t (a specific transcription factor for Th17) was also reduced. This effect was coupled with a striking reduction of IL-6 production, which has a critical role in Th17 development. In established arthritis, SM905 profoundly inhibited disease progression, reduced IL-17A and RORgamma t mRNA expression, and suppressed pro-inflammatory mediator expression in arthritic joints.

Conclusions and implications

SM905 had beneficial effects on CIA by suppressing inflammatory and pathogenic Th17 responses.

SUBMITTER: Wang JX 

PROVIDER: S-EPMC2275452 | biostudies-literature | 2008 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses.

Wang J-X JX   Tang W W   Zhou R R   Wan J J   Shi L-P LP   Zhang Y Y   Yang Y-F YF   Li Y Y   Zuo J-P JP  

British journal of pharmacology 20080211 6


<h4>Background and purpose</h4>Our previous study showed that SM905, a novel artemisinin derivative, exhibited potent immunosuppressive activity. In this study, we evaluate preventive and therapeutic effect of SM905 on collagen-induced arthritis (CIA) in DBA/1 mice, and investigate its mechanisms both in inflammatory and autoimmune aspects of the disease.<h4>Experimental approach</h4>CIA was induced by type II bovine collagen (CII) in DBA/1 mice. SM905 was given orally either before (continuousl  ...[more]

Similar Datasets

| S-EPMC3645576 | biostudies-literature
| S-EPMC5525646 | biostudies-other
| S-EPMC2567481 | biostudies-literature
| S-EPMC7510963 | biostudies-literature